Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity

Radiology

Volumn 269, Issue 2, 2013, Pages 534-541

  Bredella, Miriam A ^a   Gill, Corey M ^a   Gerweck, Anu V ^a   Landa, Melissa G ^a   Kumar, Vidhya ^a   Daley, Scott M ^a   Torriani, Martin ^a   Miller, Karen K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BONE MARROW; BONE MARROW FAT; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EXERCISE; FAT CONTENT; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIVER; MALE; NORMAL HUMAN; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUESTIONNAIRE; SIGNAL NOISE RATIO; SOLEUS MUSCLE; STEM CELL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE MARROW; EXERCISE; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OBESITY; QUESTIONNAIRES;

EID: 84886680256     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13130375     Document Type: Article

References (35)

1. Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr 2001;139(4):509-515. (Pubitemid 32977264)
2. Nielson CM, Marshall LM, Adams AL, et al. BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res 2011;26(3):496-502.
3. Bredella MA, Lin E, Gerweck AV, et al. Determinants of bone microarchitecture and mechanical properties in obese men. J Clin Endocrinol Metab 2012;97(11):4115-4122.
4. Bredella MA, Torriani M, Ghomi RH, et al. Determinants of bone mineral density in obese premenopausal women. Bone 2011;48(4):748-754.
5. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009;94(9):3387-3393.
6. Kim KC, Shin DH, Lee SY, Im JA, Lee DC. Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J 2010;51(6):857-863.
7. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic highfat diet reduces bone mineralization in mice. J Bone Miner Res 2001;16(1):182-188. (Pubitemid 32046204)
8. Tintut Y, Morony S, Demer LL. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 2004;24(2):e6-e10.
9. Moon SS, Lee YS, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 2012;42(2):423-429.
10. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106(2):171-176. (Pubitemid 30483118)
11. of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology 2007;148(7):3111-3121.
12. Takada I, Suzawa M, Matsumoto K, Kato S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci 2007;1116:182-195. (Pubitemid 350274329)
13. Gallego-Rojo FJ, Gonzalez-Calvin JL, Muñoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28(3):695-699. (Pubitemid 28405418)
14. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995;95(6):2581-2586.
15. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001;86(12):5755-5761. (Pubitemid 33152620)
16. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130(3):456-469. (Pubitemid 47208519)
17. Cramer C, Freisinger E, Jones RK, et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 2010;19(12):1875-1884.
18. Lang T, Cauley JA, Tylavsky F, et al. Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J Bone Miner Res 2010;25(3):513-519.
19. Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 2000;355(9222):2218-2219. (Pubitemid 30394332)
20. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000;283(24):3211-3216. (Pubitemid 30422038)
21. Adami S, Braga V, Guidi G, Gatti D, Gerardi D, Fracassi E. Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J Bone Miner Res 2000;15(3):599-604. (Pubitemid 30134106)
22. Jeong IK, Cho SW, Kim SW, et al. Lipid profiles and bone mineral density in preand postmenopausal women in Korea. Calcif Tissue Int 2010;87(6):507-512.
23. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006;2(1):35-43. (Pubitemid 43153647)
24. Bredella MA, Torriani M, Ghomi RH, et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 2011;19(1):49-53.
25. Bredella MA, Ghomi RH, Thomas BJ, Miller KK, Torriani M. Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellular lipids in obese and normal-weight women. J Magn Reson Imaging 2010;32(2):388-393.
26. Bredella MA, Ghomi RH, Thomas BJ, et al. Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla. J Comput Assist Tomogr 2010;34(3):372-376.
27. Bredella MA, Lin E, Brick DJ, et al. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial. Eur J Endocrinol 2012;166(4):601-611.
28. Bredella MA, Torriani M, Ghomi RH, et al. Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women. Obesity (Silver Spring) 2011;19(5):911-916.
29. Bredella MA, Torriani M, Thomas BJ, et al. Peak growth hormone-releasing hormoneargininestimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab 2009;94(10):3995-4002.
30. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30(6):672-679. (Pubitemid 23360802)
31. Tavassoli M. Marrow adipose cells and hemopoiesis: an interpretative review. Exp Hematol 1984;12(2):139-146.
32. Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009;122(5):409-414.
33. Takeda S, Elefteriou F, Karsenty G. Common endocrine control of body weight, reproduction, and bone mass. Annu Rev Nutr 2003;23:403-411. (Pubitemid 37059730)
34. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol 2001;22(8):1620-1627. (Pubitemid 32862282)
35. Abdallah BM, Ding M, Jensen CH, et al. Dlk1/FA1 is a novel endocrine regulator